Special biological issues in the management of women with schizophrenia

Jayashri Kulkarni, Emorfia Gavrilidis, Emily Hayes, Victoria Heaton, Roisin Worsley

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)


Schizophrenia is a debilitating and pervasive mental illness with devastating effects on psychological, cognitive and social wellbeing, and for which current treatment options are far from ideal. Gender differences and the influence of the female reproductive life cycle on the onset, course and symptoms of schizophrenia and the discovery of estrogen s remarkable psychoprotective properties in animal models led to the proposal of the estrogen protection hypothesis of schizophrenia. This has fueled the recent successful investigation of estradiol as a potential adjuvant therapeutic agent in the management of schizophrenia in women. This review explains the scientific rationale behind the estrogen hypothesis and how it can be clinically utilized to address concerns unique to the care of women with schizophrenia
Original languageEnglish
Pages (from-to)823 - 833
Number of pages11
JournalExpert Review of Neurotherapeutics
Issue number7
Publication statusPublished - 2012

Cite this